ICD-10 Coding for Cannabinoid Hyperemesis Syndrome(F12.20, F12.20U, F12.90)
Learn how to accurately code and document cannabinoid hyperemesis syndrome using ICD-10 codes R11.2 and F12.90. Ensure compliance and optimize reimbursement.
Complete code families applicable to Cannabinoid Hyperemesis Syndrome
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R11.2 | Nausea with vomiting, unspecified | Use when nausea and vomiting are present with a history of cannabis use. |
|
| F12.90 | Cannabis use, unspecified, uncomplicated | Use when cannabis use is present without dependence or abuse. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutCannabinoid Hyperemesis Syndrome
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Cannabinoid Hyperemesis Syndrome.
Failure to document cannabis use
Impact
Clinical: Misdiagnosis of CHS., Regulatory: Non-compliance with coding standards., Financial: Potential reimbursement issues.
Mitigation
Educate clinicians on documentation requirements.
Coding only R11.2 without F12.90
Impact
Reimbursement: May affect DRG assignment and reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient condition.
Mitigation
Always pair R11.2 with an F12 code to indicate cannabis use.
Incomplete Coding
Impact
Risk of audits due to missing F12 codes with R11.2.
Mitigation
Ensure all relevant codes are used and documented.